BRAF mutation may also indicate poor prognosis in CRC patients [65], but is only demonstrated in BRAF-mutated patients with MSS status, as reported by Roth et al. The study showed that BRAF mutations hold no prognostic significance in patients with MSI-H [66]. The gene discussed is BRAF; the disease is colorectal carcinoma.